DEA Issues Scheduling Rule for Cenobamate, Emergency Scheduling Decision for Isotonitazene
September 11, 2020 at 13:15:01 ET
Placement of Cenobamate in Schedule V (85 Fed. Reg. 51340)
A DEA final rule placing the drug cenobamate in Schedule V was published in the Federal Register on Aug. 20.
The recently approved new drug was placed in Schedule V on March 10 under an interim final rule issued through the agency’s expedited approval process (85 Fed. Reg. 13741).
No substantive comments were submitted i... Read More
